Skip to content
Trial Eligibility
Menu

Decision Support Tool for Patients With Advanced Breast Cancer

NCT07635147

This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this pilot study is to understand and improve the shared decision-making process between people with advanced breast cancer and their providers regarding their care and treatment. As part of this study, the researchers will evaluate a decision support tool called COAST that was designed to support patients and providers in having meaningful conversations. The main questions it aims to answer are: Can the COAST tool improve the quality of communication between patients and their oncology providers?

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Cancer Metastatic
  • Advanced Breast Cancer
  • Stage 4 Breast Cancer
  • Stage IV (Metastatic) Breast Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Weill Medical College of Cornell University
Last updated on ClinicalTrials.gov
August 19, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 3

  • NewYork-Presbyterian Brooklyn Methodist Hospital · Brooklyn, NY
  • NewYork-Presbyterian Medical Group Queens · Flushing, NY
  • NewYork-Presbyterian David H. Koch Center · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.